ARHGAP22
Rho GTPase-activating protein 22
Also known as: RHG22_HUMAN, RhoGAP2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7Z5H3
- Gene
- ARHGAP22
- Ensembl
- ENSG00000128805
- Chromosome
- 10
- Canonical length
- 698 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Plasma membrane,Cytosol
OverviewNCBI Gene
This gene encodes a member of the GTPase activating protein family which activates a GTPase belonging to the RAS superfamily of small GTP-binding proteins. The encoded protein is insulin-responsive, is dependent on the kinase Akt and requires the Akt-dependent 14-3-3 binding protein which binds sequentially to two serine residues. The result of these interactions is regulation of cell motility. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
Canonical amino-acid sequenceUniProt
698 residues, UniProt reviewed canonical sequence.
>Q7Z5H3|ARHGAP22
1 MLSPKIRQAR RARSKSLVMG EQSRSPGRMP CPHRLGPVLK AGWLKKQRSI MKNWQQRWFV
61 LRGDQLFYYK DKDEIKPQGF ISLQGTQVTE LPPGPEDPGK HLFEISPGGA GEREKVPANP
121 EALLLMASSQ RDMEDWVQAI RRVIWAPLGG GIFGQRLEET VHHERKYGPR LAPLLVEQCV
181 DFIRERGLTE EGLFRMPGQA NLVRDLQDSF DCGEKPLFDS TTDVHTVASL LKLYLRELPE
241 PVVPFARYED FLSCAQLLTK DEGEGTLELA KQVSNLPQAN YNLLRYICKF LDEVQAYSNV
301 NKMSVQNLAT VFGPNILRPQ VEDPVTIMEG TSLVQHLMTV LIRKHSQLFT APVPEGPTSP
361 RGGLQCAVGW GSEEVTRDSQ GEPGGPGLPA HRTSSLDGAA VAVLSRTAPT GPGSRCSPGK
421 KVQTLPSWKS SFRQPRSLSG SPKGGGSSLE VPIISSGGNW LMNGLSSLRG HRRASSGDRL
481 KDSGSVQRLS TYDNVPAPGL VPGIPSVASM AWSGASSSES SVGGSLSSCT ACRASDSSAR
541 SSLHTDWALE PSPLPSSSED PKSLDLDHSM DEAGAGASNS EPSEPDSPTR EHARRSEALQ
601 GLVTELRAEL CRQRTEYERS VKRIEEGSAD LRKRMSRLEE ELDQEKKKYI MLEIKLRNSE
661 RAREDAERRN QLLQREMEEF FSTLGSLTVG AKGARAPKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARHGAP22 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 37 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 37 nTPM
- midbrain: 22 nTPM
- hippocampal formation: 15 nTPM
- amygdala: 12 nTPM
- hypothalamus: 12 nTPM
- cerebral cortex: 8.5 nTPM
Single-cell type
- microglia: 1,231 nCPM
- late spermatids: 251 nCPM
- oligodendrocytes: 247 nCPM
- early spermatids: 215 nCPM
- oligodendrocyte progenitor cells: 202 nCPM
- fibro-adipogenic progenitors: 154 nCPM
Immune cell
- classical monocyte: 1.1 nTPM
- myeloid DC: 0.9 nTPM
- naive B-cell: 0.6 nTPM
- total PBMC: 0.3 nTPM
- non-classical monocyte: 0.2 nTPM
- intermediate monocyte: 0.1 nTPM
Brain region
- medulla oblongata: 40 nTPM
- white matter: 36 nTPM
- pons: 33 nTPM
- cerebellum: 28 nTPM
- midbrain: 26 nTPM
- spinal cord: 26 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.92
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.6
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- cell differentiation
- negative regulation of small GTPase mediated signal transduction
- regulation of postsynapse organization
- regulation of small GTPase mediated signal transduction
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ARHGAP22 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARHGAP22 as an antibody target. Whether an autoantibody or antibody against ARHGAP22 could matter depends on whether native ARHGAP22 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARHGAP22 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ARHGAP22 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...